Women working in the lab

About Us

A trusted
CDMO team

As a subsidiary of SK Inc., SK pharmteco is backed by the strength and stability of one of South Korea’s largest business networks. Drawing from our long-standing industry presence, we leverage our expertise, technology, and legacy of innovation to navigate the complexities of advancing small molecule and cell and gene therapies. Our integrated service offerings cover process and analytical method development, optimization, validation, analytical testing, and commercial production. Working beside our customers throughout their entire journey, we operate as ‘One Team’, collaborating on a foundation of trust and common purpose to develop and deliver therapies that change lives.

Learn more about our history

Our company
culture

Our mission

We are committed to changing the world through our unwavering dedication to life saving therapies. We enable our partners with advanced technology, expertise, and customer-centricity, allowing them to bring breakthrough treatments to patients and deliver happiness and health to stakeholders everywhere.

Our vision

To be the most trusted global partner in the delivery of innovative medicines.

Our Values

Customer Dedication

Our goal is to always delight and support customers by meeting or exceeding their expectations.

Willingness to Take Ownership

We aim to engage willingly, giving our best for the benefit of all stakeholders while striving to take full ownership of our work and pride in our results.

Trust

We are committed to building trust by always acting with integrity. We ensure openness and transparency in our operations and communications.

Respect & Sensitivity

We are dedicated to respecting and helping one another, embracing diversity and unique experiences while being sensitive to the well-being of our customers. Additionally, we are committed to supporting our people’s personal growth and development.

Flexibility & Creativity

We strive to be agile and adaptable to changing customer and patient needs while valuing, encouraging, and supporting creativity and continuous improvement. We also invest in an interesting, challenging, and rewarding working environment.

Commitment to Excellence

We relentlessly strive for excellence in everything we do, constantly seeking ways to improve and deliver the 
highest quality.

Our environmental, social & governance commitment

Environmental

At SK pharmteco, we prioritize reducing our environmental impact through renewable energy, emission reduction, and environmental enhancement. It is our belief and the belief of our parent company, that great companies must lead by example when it comes to environmental sustainability. 

We apply decades of experience in green chemistry, continuous flow processing, and other sustainable manufacturing approaches throughout our projects. Our strong commitment to environmental stewardship provides our customers with a better way to create their therapeutic products, minimizing potential ecological impact while meeting all regulatory requirements to provide safe and efficacious drugs to their patients. 

Together, these actions reflect our commitment to shaping a sustainable future and achieving a net-zero carbon target by 2040.

At SK pharmteco, we prioritize reducing environmental impact through renewable energy, emissions reduction, and green chemistry. We arecommitted to a net-zero carbon target by 2040.

Our environmental, social & governance commitment

Social

We seek to be a good neighbor in all we do, investing in education, community involvement, global health and welfare, and diversity, equity, and inclusion (DE&I). 

Our environmental, social & governance commitment

Governance

SK pharmteco maintains a culture of ethics and transparency through ongoing measures in risk management, corporate citizenship, and an organizational commitment to ethical behavior.

Joerge Ahlgrimm
“At SK pharmteco our mission is to build strong relationships that create happiness for our customers through the shared goal of producing and delivering life-changing therapies that improve patient outcomes and save lives. With our network of seven global, cutting-edge, facilities our capabilities cover the entire product lifecycle, from initial development to commercial manufacturing. We work with customers in a flexible ‘One Team’ approach, prioritizing collaboration, transparency, and trust to make every interaction easy and seamless.”
Joerg Ahlgrimm, CEO

Learn more about
SK pharmteco

Service Excellence

Learn more

Compliance, Ethics & Transparency

Learn more

Careers

Learn more

Leadership

Learn more

Locations

Learn more

Our company history

1996

SK Inc. launches its CDMO business

1999

Constructs its first commercial plant in Korea, later known as SK biotek

2003 – 2006

SK biotek continues momentum in advancing CDMO capabilities, investing in the construction of a full continuous process plant and scaling up for flow chemistry in its pilot plant

2017

SK Inc. acquires the Swords, Ireland facility, creating SK biotek Ireland

2018

Acquires AMPAC Fine Chemicals, a U.S.-based custom manufacturer of small-molecule pharmaceutical chemicals

2019

SK Inc. establishes SK pharmteco, a U.S.-based operational holding company for its CDMO business

2021

SK pharmteco enters the cell and gene therapy space, acquiring Yposkesi, a French CDMO focused on viral vector production. The same year, SK pharmteco invests in the Center for Breakthrough Medicines, an innovative and industry-leading cell and gene therapy CDMO based in Pennsylvania, U.S.

2023

SK pharmteco acquires a controlling interest in the Center for Breakthrough Medicines and integrates its capabilities with Yposkesi, expanding capacity and enabling full-service, end-to-end cell and gene therapy CDMO solutions

Contact us

We’re committed to supporting your development and manufacturing needs. Complete the form and someone from SK pharmteco will be in touch shortly.